PRESSURE BIOSCIENC COM USD0.01 (PBIO)

0.38
OTC Markets
Prev Close 0.38
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.20 / 0.58
Exchange OTC Markets
Shares Outstanding 29.03B
Market Cap 10.45M
Div & Yield N.A. (N.A)

Latest News

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel "Understanding Reg A+ and the 'Mini IPO'"

Pressure BioSciences To Participate In SCIEX Workshop On New Innovations Towards Industrialized Proteomics At US HUPO Conference

Pressure BioSciences To Participate In SCIEX Workshop On New Innovations Towards Industrialized Proteomics At US HUPO Conference

SCIEX Seminar Will Focus on Using Industrialized Omics to Perform Translational Research Needed to Enable Precision Medicine

SCIEX Announces Exclusive Co-Marketing Agreement With Pressure BioSciences, Inc. To Improve Protein Quantitation In Complex Samples

SCIEX Announces Exclusive Co-Marketing Agreement With Pressure BioSciences, Inc. To Improve Protein Quantitation In Complex Samples

SCIEX, a global leader in life science analytical technologies, today announced an exclusive co-marketing agreement with Pressure BioSciences, Inc.

Pressure BioSciences And Florida International University Enter Into Formal Agreement To Develop An Improved Rape Kit Test Method Based On PBI's Patented PCT Platform

Pressure BioSciences And Florida International University Enter Into Formal Agreement To Develop An Improved Rape Kit Test Method Based On PBI's Patented PCT Platform

Collaboration Will Combine the Advantages of PBI's PCT Platform with the Forensic Experience and Expertise of FIU, with a Goal to Help Reduce the Rape Kit Testing Backlog

New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role In Personalized/Precision Medicine

New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role In Personalized/Precision Medicine

Key Protein Scientists Report Unique Benefits of the PCT Platform in the Analysis of Critical Samples, Such as Cancer Tissue Biopsies and Stem Cells

Pressure BioSciences Closes $2,180,000 Initial Tranche Of A $5 Million Private Placement

Pressure BioSciences Closes $2,180,000 Initial Tranche Of A $5 Million Private Placement

Senior Secured Convertible Debenture Offering Closed at Market Price with Common Stock Warrants Exercisable at a 43% Premium; Proceeds Will Support Expansion of Marketing and Sales Team and Pay-down of Convertible Debt

Pressure BioSciences' PCT Platform Results In A Promising New Method For Improved Extraction Of DNA From Rape Kits And Other Forensic Samples

Pressure BioSciences' PCT Platform Results In A Promising New Method For Improved Extraction Of DNA From Rape Kits And Other Forensic Samples

Novel PCT-enhanced Method for Selective Extraction of DNA from Male or Female Cells Collected on Cotton Swabs Published in Major Scientific Journal

Pressure BioSciences, Inc. To Present At The 3rd Global Life Sciences Conference In Warsaw Poland

Pressure BioSciences, Inc. To Present At The 3rd Global Life Sciences Conference In Warsaw Poland

Conference Will Introduce Key European Institutional Investors to Executives from Leading MicroCap Companies within the Global Life Sciences Universe

Data From Recently Published Studies Provide Strong Support For Current And Future Applications Of Pressure BioSciences' PCT Platform

Data From Recently Published Studies Provide Strong Support For Current And Future Applications Of Pressure BioSciences' PCT Platform

Results of Studies by Three Key Opinion Leader Laboratories Demonstrate Significant Advantages in Drug Discovery, Cancer Detection, and in the Analysis of Microorganism Diversity in Soil

Novel Environmental Epidemiology Application For Pressure BioSciences' Barozyme HT48 High-throughput System Developed

Novel Environmental Epidemiology Application For Pressure BioSciences' Barozyme HT48 High-throughput System Developed

Scientists from the Northwestern University's Feinberg School of Medicine Report on the Development of an Enhanced Method for Determining Fetal Exposure to Maternal Smoke and Potentially Other Environmental Pollutants Using the Recently Released Barozyme HT48 System. Company Believes These New Applications Will Help Drive Revenue in 2015 and Beyond.

Pressure BioSciences Ships Third Barozyme HT48 System

Pressure BioSciences Ships Third Barozyme HT48 System

Evaluation of PBI's New High-Throughput PCT-based System Commences at a Top Ranked U.S. Medical School

Pressure BioSciences Ships First Two Barozyme HT48 Systems

Pressure BioSciences Ships First Two Barozyme HT48 Systems

Evaluations of PBI's New High-Throughput PCT-based System Underway at a World Renowned Academic/Research Institution and a Leading Biotechnology Company. Additional Evaluations at Key Opinion Leader Laboratories Scheduled.

Breakthrough Method To Permit Quantification Of Thousands Of Proteins In Needle Biopsy Samples In 12 Hours Presented At Major International Scientific Meeting; Method Enabled By Pressure BioSciences' PCT Sample Preparation Platform

Breakthrough Method To Permit Quantification Of Thousands Of Proteins In Needle Biopsy Samples In 12 Hours Presented At Major International Scientific Meeting; Method Enabled By Pressure BioSciences' PCT Sample Preparation Platform

PCT-dependent Method Provides High Quality Mass Spectrometry-based Proteomic Analysis in Small Needle Biopsy Samples for the First Time, Offering Potential to Vastly Improve Drug Discovery and Design Programs and Diagnostic Insights in Research and Clinical Laboratories Worldwide

Pressure BioSciences Announces Partnership With Powertech Technology Company Ltd. To Develop China Market For PBI's PCT Platform

Pressure BioSciences Announces Partnership With Powertech Technology Company Ltd. To Develop China Market For PBI's PCT Platform

Powertech Offers Strong Distribution and Support Network of 20 Offices/Laboratories, Over 60 Sales/Marketing/Service/Engineering Staff, and Multiple Sub-dealers Throughout China

Pressure BioSciences, Inc. Invited To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland

Pressure BioSciences, Inc. Invited To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland

Conference Expected to Bring Together Executives from Leading MicroCap Companies Within the Global Life Sciences Universe with European Institutional Investors

Pressure BioSciences Announces Completion Of The First Phase Of Its Commercialization Plan For The Barozyme HT48, The Company's Recently Released High Throughput PCT-based Instrument System

Pressure BioSciences Announces Completion Of The First Phase Of Its Commercialization Plan For The Barozyme HT48, The Company's Recently Released High Throughput PCT-based Instrument System

The Company Expects to Build and Ship Nine Instrument Systems for Evaluation between Mid-October and Late November. The Company Believes One or More Systems will be Purchased by the Evaluating Laboratories, Impacting Q4 2014 Revenue

Pressure BioSciences Engages IssuWorks In Strategic Advisory Role

Pressure BioSciences Engages IssuWorks In Strategic Advisory Role

David Weild IV, Former Vice Chairman of the NASDAQ Stock Market and Wall Street Veteran, and Edward H. Kim, Former Sr. Vice President of NASDAQ and Biotech Analyst, to Advise the Company on Growth Strategies, Including Strategic and Financing Alternatives

Launch Of Novel, High Throughput PCT-based Barozyme HT48 System

Launch Of Novel, High Throughput PCT-based Barozyme HT48 System "Very Successful" Says Pressure BioSciences

Company Believes It Met Every Key Objective for Its Product Launch, Reiterates Expectation to Secure One or More Strategic Marketing/Sales Partners by Year's End, and Reaffirms Guidance for Sales of Its New PCT Microplate Strip System to Begin in the 2H 2014

Pressure BioSciences To Launch Its Much Anticipated High Throughput PCT-based Instrument System (the Barozyme HT48) At The Upcoming ASMS Annual Conference

Pressure BioSciences To Launch Its Much Anticipated High Throughput PCT-based Instrument System (the Barozyme HT48) At The Upcoming ASMS Annual Conference

The Company Believes the Barozyme HT48 High Throughput System Can Significantly Fuel Growth and Increase Revenue for Existing and New PCT-based Applications and Products, and Greatly Facilitate the Commencement of New Strategic Partnerships